Fredun Pharmaceuticals Ltd, a active public limited company, was established on 08 June 1987 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1987PLC043662. Registered under ROC Roc Mumbai. it is listed on BSE: 539730. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹4.72 Cr.
Formerly known as Fredun Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹349.07 Cr and a net worth of ₹121.47 Cr. Employing 264 professional, Its leadership includes Daisy Dsouza (Director), Daulat Nariman Medhora (Whole-Time Director), Fredun Nariman Medhora (Managing Director). Past directors included Chandrakant Kanchanlal Shah, Nariman Bamansha Medhora, Ankita Kishor Joshi. It holds ₹245.23 Cr open charges and ₹136.27 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at 11Th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Mumbai, Maharashtra, 400013.
L24239MH1987PLC043662
043662
08 June 1987
₹10.00 Cr
₹4.72 Cr
Roc Mumbai
Listed (BSE: 539730)
Active
Explore comprehensive insights into Fredun Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Daisy Dsouza | Director | 24 Nov 2023 | Current |
| Daulat Nariman Medhora | Whole-Time Director | 08 Jun 1987 | Current |
| Fredun Nariman Medhora | Managing Director | 15 Sep 2006 | Current |
| Anshu Gyan Agarwal | Additional Director | 30 Jul 2025 | Current |
| Sonal Dharmin Desai | Additional Director | 30 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jul 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Jun 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 03 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 17 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fredun Pharmaceuticals Ltd, for the financial year ended 2024, experienced significant growth in revenue, with a 26.25% increase. The company also saw a substantial improvement in profitability, with a 44.57% increase in profit. The company's net worth Soared by an impressive increase of 26.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Fredun Pharmaceuticals had a promoter holding of 49.17% and a public holding of 50.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,452,281,989.00
₹1,362,674,893.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2025 | Axis Bank Limited | ₹2.32 M | Open |
| 23 Sep 2025 | Axis Bank Limited | ₹2.49 M | Open |
| 22 Sep 2025 | Axis Bank Limited | ₹7.00 M | Open |
| 04 Sep 2025 | Others | ₹2.50 Cr | Open |
| 22 Aug 2025 | Hdfc Bank Limited | ₹22.50 Cr | Open |
Explore comprehensive loan charge details -
Fredun Pharmaceuticals has a workforce of 264 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Fredun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fredun Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Fredun Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
A charge with Axis Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101171165 was registered on 23 Sep 2025. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 0.25 Cr with Charge ID 101171164 was registered on 23 Sep 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 0.70 Cr with Charge ID 101171160 was registered on 22 Sep 2025. was completed.
The activity A charge with Others amounted to Rs. 2.50 Cr with Charge ID 101161373 was registered on 04 Sep 2025. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 22.50 Cr with Charge ID 101155710 was registered on 22 Aug 2025. was documented.
The CIN of Fredun Pharmaceuticals Ltd is L24239MH1987PLC043662.
Fredun Pharmaceuticals Ltd is headquartered at 11Th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Mumbai, Maharashtra, 400013.
Fredun Pharmaceuticals Ltd was incorporated on 08 June 1987.
The current directors of Fredun Pharmaceuticals Ltd are
The primary industry of Fredun Pharmaceuticals Ltd is Manufacturing.
Fredun Pharmaceuticals Ltd is listed. It is listed on BSE: 539730.
The authorized capital of Fredun Pharmaceuticals Ltd is ₹10.00 Cr, and the paid-up capital is ₹4.72 Cr.
The compliance status of Fredun Pharmaceuticals Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX